Bioelectronics Corp (BIEL)

[JNdouble1]

"Sorry, high risk fda play"

I think the point is understood, but this is no longer an FDA play.

Sure, there is room for even more indications that need approval. And there is always room for new versions of the device that require subsequent clearance from the agency.

Since we have all the approvals we need to either succeed or fail in the markets worldwide, this is now more of a do or die will it sell play. Of course being a pink sheet OTC stock, there are opportunities for trades against news. The upcoming Synergy news will brink a big price increase I hear.